IHC of SSTR2 was performed for 202 tumor samples including 25/202 (12.4%) metastatic cases: 101/202 (50.0%) showed positive staining for SSTR2 by IHC (strong SSTR2 staining: 35/202, 17.3%; moderate SSTR2 staining: 66/202, 32.7%) (Figure 1 (30)). This evidence concerns the gene SSTR2 and neoplasm.